<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03488576</url>
  </required_header>
  <id_info>
    <org_study_id>Vitreo003</org_study_id>
    <nct_id>NCT03488576</nct_id>
  </id_info>
  <brief_title>Foveal Sparing of the ILM</brief_title>
  <official_title>Macular Peeling With Foveal Sparing of the Internal Limiting Membrane: A Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Università degli Studi di Brescia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Università degli Studi di Brescia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To compare the retinal sensitivity of complete internal limiting membrane (ILM) peeling
      versus foveal sparing ILM peeling during vitrectomy for epiretinal membrane or macular hole.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 1, 2014</start_date>
  <completion_date type="Actual">June 30, 2017</completion_date>
  <primary_completion_date type="Actual">December 31, 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>This was a prospective study including ninety-one eyes of 190 phakic patients scheduled to undergo vitrectomy for idiopathic macular pucker or macular hole, from July 2014 to December 2016. Patients were randomized in a 1:1 ratio to complete peeling of the ILM (CP group) or foveal sparing (FS group).</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Retinal Sensitivity (dB)</measure>
    <time_frame>12-month</time_frame>
    <description>Microperimetry was done to assess macular sensitivity</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Visual Acuity (LogMAR)</measure>
    <time_frame>12-month</time_frame>
    <description>ETDRS charts were used to assess best corrected visual acuity</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Central Retinal Thickness (microns)</measure>
    <time_frame>12-month</time_frame>
    <description>Optical Coherence Tomography will be used to assess central retinal thickness</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">190</enrollment>
  <condition>Retinal Sensitivity</condition>
  <arm_group>
    <arm_group_label>Complete Peeling</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patient underwent scheduled vitrectomy for epiretinal membrane or macular hole with complete macular peeling of the internal limiting membrane.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Foveal Sparing</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patient underwent scheduled vitrectomy for epiretinal membrane or macular hole with partial peeling the internal limiting membrane (foveal sparing).</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Complete Macular Peeling</intervention_name>
    <description>A complete peeling of the internal limiting membrane was performed</description>
    <arm_group_label>Complete Peeling</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Macular Peeling with Foveal Sparing</intervention_name>
    <description>A partial peeling of the internal limiting membrane was performed, sparing the fovea.</description>
    <arm_group_label>Foveal Sparing</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  provision of written informed consent

          -  age &gt; 60 years

          -  presence of idiopathic macular pucker or macular hole documented by OCT

        Exclusion Criteria:

          -  any prior intraocular surgery

          -  pathologic myopia (&gt; 7 diopters)

          -  age related macular degeneration

          -  glaucoma and diabetic retinopathy or any other retinal vascular disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 28, 2018</study_first_submitted>
  <study_first_submitted_qc>March 28, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 5, 2018</study_first_posted>
  <last_update_submitted>March 28, 2018</last_update_submitted>
  <last_update_submitted_qc>March 28, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 5, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Università degli Studi di Brescia</investigator_affiliation>
    <investigator_full_name>Francesco Semeraro</investigator_full_name>
    <investigator_title>Francesco Semeraro; MD, Associate Professor</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

